Brenner, Amy http://orcid.org/0000-0003-2017-5994
Arribas, Monica
Cuzick, Jack
Jairath, Vipul
Stanworth, Simon
Ker, Katharine
Shakur-Still, Haleema
Roberts, Ian
Funding for this research was provided by:
Health Technology Assessment Programme (11/01/04)
Article History
Received: 21 May 2018
Accepted: 3 September 2018
First Online: 1 October 2018
Ethics approval and consent to participate
: We conducted the CRASH-2, WOMAN and HALT-IT trials in accordance with good clinical practice guidelines. The relevant ethics committees and regulatory agencies approved the consent procedures. We obtained informed consent from the patient if physical and mental capacity allowed. If a person could not give consent, we obtained proxy consent from a relative or representative. If no proxy was available, then if local regulation allowed, we deferred or waived the consent. In these cases, we told the patient about the trial as soon as possible and obtained consent for use of the data collected.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.